Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway

Purpose: To evaluate the potential efficacy of Triptolide (TP) on cerebral ischemia/reperfusion injury (CIRI) and to uncover the underlying mechanism through which TP regulates CIRI. Methods: We constructed a middle cerebral artery occlusion/reperfusion (MCAO/R) mouse model to simulate CIRI, and est...

Full description

Bibliographic Details
Main Authors: Jiajun Zhou, Wei Ye, Ling Chen, Junheng Li, Yijun Zhou, Chunfeng Bai, Lian Luo
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Brain Research Bulletin
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0361923024000728
_version_ 1827274365318725632
author Jiajun Zhou
Wei Ye
Ling Chen
Junheng Li
Yijun Zhou
Chunfeng Bai
Lian Luo
author_facet Jiajun Zhou
Wei Ye
Ling Chen
Junheng Li
Yijun Zhou
Chunfeng Bai
Lian Luo
author_sort Jiajun Zhou
collection DOAJ
description Purpose: To evaluate the potential efficacy of Triptolide (TP) on cerebral ischemia/reperfusion injury (CIRI) and to uncover the underlying mechanism through which TP regulates CIRI. Methods: We constructed a middle cerebral artery occlusion/reperfusion (MCAO/R) mouse model to simulate CIRI, and established a lipopolysaccharide (LPS)-stimulated BV-2 cell model to mimic the inflammatory state during CIRI. The neurological deficits score (NS) of mice were measured for assessment of neurologic functions. Both the severity of cerebral infarction and the apoptosis level in mouse brain tissues or cells were respectively evaluated using corresponding techniques. The expression levels of Ionized calcium binding adapter molecule 1 (IBA-1), Inductible Nitric Oxide Synthase (iNOS), Arginase 1 (Arg-1), Tumor necrosis factor-α (TNF-α), Interleukin 1β (IL-1β), Cysteine histoproteinase S (CTSS), Fractalkine, chemokine C-X3-C motif receptor 1 (CX3CR1), BCL-2-associated X protein (BAX), and antiapoptotic proteins (Bcl-2) were detected using immunofluorescence, qRT-PCR as well as Western blot, respectively. Results: Relative to the Sham group, treatment with TP attenuated the increased NS, infarct area and apoptosis levels observed in MCAO/R mice. Upregulated expression levels of IBA-1, iNOS, Arg-1, TNF-α and IL-1β were found in MCAO/R mice, while TP suppressed iNOS, TNF-α and IL-1β expression, and enhanced Arg-1 expression in both MCAO/R mice and LPS-stimulated BV-2 cells. Besides, TP inhibited the CTSS/Fractalkine/CX3CR1 pathway activation in both MCAO/R mice and LPS-induced BV-2 cells, while overexpression of CTSS reversed such effect. Co-culturing HT-22 cells with TP+LPS-treated BV-2 cells led to enhanced cell viability and decreased apoptosis levels. However, overexpression of CTSS further aggravated HT-22 cell injury. Conclusion: TP inhibits not only microglia polarization towards the M1 phenotype by suppressing the CTSS/Fractalkine/CX3CR1 pathway activation, but also HT-22 apoptosis by crosstalk with BV-2 cells, thereby ameliorating CIRI. These findings reveal a novel mechanism of TP in improving CIRI, and offer potential implications for addressing the preventive and therapeutic strategies of CIRI.
first_indexed 2024-04-24T13:11:50Z
format Article
id doaj.art-8115e6af3ce249eca86c26982fc0dcd0
institution Directory Open Access Journal
issn 1873-2747
language English
last_indexed 2025-03-22T06:23:51Z
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Brain Research Bulletin
spelling doaj.art-8115e6af3ce249eca86c26982fc0dcd02024-04-26T04:58:14ZengElsevierBrain Research Bulletin1873-27472024-06-01211110939Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathwayJiajun Zhou0Wei Ye1Ling Chen2Junheng Li3Yijun Zhou4Chunfeng Bai5Lian Luo6Department of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Liver Diseases, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Affiliated Hangzhou Xixi Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, China; Corresponding author.Purpose: To evaluate the potential efficacy of Triptolide (TP) on cerebral ischemia/reperfusion injury (CIRI) and to uncover the underlying mechanism through which TP regulates CIRI. Methods: We constructed a middle cerebral artery occlusion/reperfusion (MCAO/R) mouse model to simulate CIRI, and established a lipopolysaccharide (LPS)-stimulated BV-2 cell model to mimic the inflammatory state during CIRI. The neurological deficits score (NS) of mice were measured for assessment of neurologic functions. Both the severity of cerebral infarction and the apoptosis level in mouse brain tissues or cells were respectively evaluated using corresponding techniques. The expression levels of Ionized calcium binding adapter molecule 1 (IBA-1), Inductible Nitric Oxide Synthase (iNOS), Arginase 1 (Arg-1), Tumor necrosis factor-α (TNF-α), Interleukin 1β (IL-1β), Cysteine histoproteinase S (CTSS), Fractalkine, chemokine C-X3-C motif receptor 1 (CX3CR1), BCL-2-associated X protein (BAX), and antiapoptotic proteins (Bcl-2) were detected using immunofluorescence, qRT-PCR as well as Western blot, respectively. Results: Relative to the Sham group, treatment with TP attenuated the increased NS, infarct area and apoptosis levels observed in MCAO/R mice. Upregulated expression levels of IBA-1, iNOS, Arg-1, TNF-α and IL-1β were found in MCAO/R mice, while TP suppressed iNOS, TNF-α and IL-1β expression, and enhanced Arg-1 expression in both MCAO/R mice and LPS-stimulated BV-2 cells. Besides, TP inhibited the CTSS/Fractalkine/CX3CR1 pathway activation in both MCAO/R mice and LPS-induced BV-2 cells, while overexpression of CTSS reversed such effect. Co-culturing HT-22 cells with TP+LPS-treated BV-2 cells led to enhanced cell viability and decreased apoptosis levels. However, overexpression of CTSS further aggravated HT-22 cell injury. Conclusion: TP inhibits not only microglia polarization towards the M1 phenotype by suppressing the CTSS/Fractalkine/CX3CR1 pathway activation, but also HT-22 apoptosis by crosstalk with BV-2 cells, thereby ameliorating CIRI. These findings reveal a novel mechanism of TP in improving CIRI, and offer potential implications for addressing the preventive and therapeutic strategies of CIRI.http://www.sciencedirect.com/science/article/pii/S0361923024000728Cerebral ischemia/reperfusion injuryTriptolideCTSSFractalkineCX3CR1
spellingShingle Jiajun Zhou
Wei Ye
Ling Chen
Junheng Li
Yijun Zhou
Chunfeng Bai
Lian Luo
Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
Brain Research Bulletin
Cerebral ischemia/reperfusion injury
Triptolide
CTSS
Fractalkine
CX3CR1
title Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
title_full Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
title_fullStr Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
title_full_unstemmed Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
title_short Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
title_sort triptolide alleviates cerebral ischemia reperfusion injury via regulating the fractalkine cx3cr1 signaling pathway
topic Cerebral ischemia/reperfusion injury
Triptolide
CTSS
Fractalkine
CX3CR1
url http://www.sciencedirect.com/science/article/pii/S0361923024000728
work_keys_str_mv AT jiajunzhou triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT weiye triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT lingchen triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT junhengli triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT yijunzhou triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT chunfengbai triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway
AT lianluo triptolidealleviatescerebralischemiareperfusioninjuryviaregulatingthefractalkinecx3cr1signalingpathway